Comunicati Stampa
Salute e Benessere

Notification of managers' transactions

ANNOUNCEMENT NO. 283 8 November 2024 Notification of managers' transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them.See the transactions of the CEO Martin Helbo Behrens in the attached PDF document.For further information, please contact:Kim...
Allerød, (informazione.it - comunicati stampa - salute e benessere)

ANNOUNCEMENT NO. 283

8 November 2024

Notification of managers' transactions

ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them.

See the transactions of the CEO Martin Helbo Behrens in the attached PDF document.

For further information, please contact:

Kim Nicolajsen, CFO
Telephone (+45) 48 13 10 20

About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec's instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to www.chemometec.com .

Attachment


Per maggiori informazioni
Sito Web
chemometec.com
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Non disponibili